Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 133

1.

Echocardiographic assessment of tricuspid regurgitation and pericardial effusion after cardiac device implantation.

Jabłońska K, Wiechecki B, Kapłon-Cieślicka A, Tymińska A, Budnik M, Hołowaty D, Jakubowski K, Michalak M, Świętoń E, Stolarz P, Steckiewicz R, Grabowski M, Scisło P, Kochanowski J, Filipiak KJ, Opolski G.

Cardiol J. 2019 Jun 21. doi: 10.5603/CJ.a2019.0053. [Epub ahead of print]

2.

Impact of anticoagulation therapy on outcomes in patients with cardiac implantable resynchronization devices undergoing transvenous lead extraction: A substudy of the ESC-EHRA EORP ELECTRa (European Lead Extraction ConTRolled) Registry.

Regoli F, Auricchio A, Di Cori A, Segreti L, Blomström-Lunqvist C, Butter C, Deharo JC, Kennergren C, Kutarski A, Laroche C, Zalevskiy V, Luzzi G, Cano O, Grabowski M, Rinaldi C, Bongiorni MG.

J Cardiovasc Electrophysiol. 2019 Jul;30(7):1086-1095. doi: 10.1111/jce.13946. Epub 2019 Apr 29.

PMID:
30980441
3.

The role of hemostatic markers as venous stenosis or occlusion predictors following first transvenous cardiac device implantation.

Cacko A, Kozyra-Pydyś E, Gawałko M, Opolski G, Grabowski M.

Cardiol J. 2019 Mar 26. doi: 10.5603/CJ.a2019.0030. [Epub ahead of print]

4.

Recommendations on the use of innovative medical technologies in cardiology and cardiac surgery and solutions leading to increased availability for Polish patients.

Dudek D, Banasiak W, Braksator W, Dubiel J, Grodzicki T, Hoffman P, Kuśmierczyk M, Opolski G, Ponikowski P, Różański J, Sadowski J, Wojakowski W, Grabowski M, Bondaryk K, Walczak J, Pieniążek I, Grys M, Lesiak-Bednarek A, Przygodzki P.

Cardiol J. 2019;26(2):114-129. doi: 10.5603/CJ.a2019.0007. Epub 2019 Feb 14.

5.

Acute superior vena cava syndrome related to cardiac implantable electronic devices: a rare but potentially serious complication.

Jonik S, Januszkiewicz Ł, Grabowski M, Michalak M, Opolski G, Mitkowski P.

Kardiol Pol. 2019;77(1):64. doi: 10.5603/KP.2019.0009. No abstract available.

6.

Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.

Ozierański K, Balsam P, Kapłon-Cieślicka A, Tymińska A, Kowalik R, Grabowski M, Peller M, Wancerz A, Marchel M, Crespo-Leiro MG, Maggioni AP, Drożdż J, Filipiak KJ, Opolski G.

Cardiovasc Drugs Ther. 2019 Feb;33(1):77-86. doi: 10.1007/s10557-018-6843-5.

PMID:
30649675
7.

Differences in clinical characteristics and 1-year outcomes of hospitalized patients with heart failure in ESC-HF Pilot and ESC-HF-LT registries.

Balsam P, Ozierański K, Kapłon-Cieślicka A, Borodzicz S, Tymińska A, Peller M, Marchel M, Crespo-Leiro MG, Maggioni AP, Drożdż J, Opolski G, Grabowski M.

Pol Arch Intern Med. 2019 Feb 28;129(2):106-116. doi: 10.20452/pamw.4418. Epub 2019 Jan 16.

8.

Kardia Mobile applicability in clinical practice: A comparison of Kardia Mobile and standard 12-lead electrocardiogram records in 100 consecutive patients of a tertiary cardiovascular care center.

Koltowski L, Balsam P, Glłowczynska R, Rokicki JK, Peller M, Maksym J, Blicharz L, Maciejewski K, Niedziela M, Opolski G, Grabowski M.

Cardiol J. 2019 Jan 15. doi: 10.5603/CJ.a2019.0001. [Epub ahead of print]

9.

Predictors of venous stenosis or occlusion following first transvenous cardiac device implantation: Prospective observational study.

Cacko A, Kozyra-Pydyś E, Gawałko M, Opolski G, Grabowski M.

J Vasc Access. 2019 Sep;20(5):495-500. doi: 10.1177/1129729818815135. Epub 2018 Dec 11.

PMID:
30537896
10.

A Study on Microturning with Electrochemical Assistance of the Cutting Process.

Grabowski M, Skoczypiec S, Wyszynski D.

Micromachines (Basel). 2018 Jul 19;9(7). pii: E357. doi: 10.3390/mi9070357.

11.

Clinical characteristics and thromboembolic risk of atrial fibrillation patients with and without congestive heart failure. Results from the CRATF study.

Balsam P, Gawałko M, Peller M, Tymińska A, Ozierański K, Zaleska M, Żukowska K, Szepietowska K, Maciejewski K, Grabowski M, Borkowski M, Kołtowski Ł, Praska-Oginska A, Zaboyska I, Opolski G, Bednarski J.

Medicine (Baltimore). 2018 Nov;97(45):e13074. doi: 10.1097/MD.0000000000013074.

12.

Randomized controlled clinical trials versus real-life atrial fibrillation patients treated with oral anticoagulants. Do we treat the same patients?

Balsam P, Tymińska A, Ozierański K, Zaleska M, Żukowska K, Szepietowska K, Maciejewski K, Peller M, Grabowski M, Lodziński P, Kołtowski Ł, Praska-Ogińska A, Zaboyska I, Bednarski J, Filipiak KJ, Opolski G.

Cardiol J. 2018 Nov 8. doi: 10.5603/CJ.a2018.0135. [Epub ahead of print]

13.

Wearable Cardioverter-Defibrillator after Myocardial Infarction.

Olgin JE, Pletcher MJ, Vittinghoff E, Wranicz J, Malik R, Morin DP, Zweibel S, Buxton AE, Elayi CS, Chung EH, Rashba E, Borggrefe M, Hue TF, Maguire C, Lin F, Simon JA, Hulley S, Lee BK; VEST Investigators.

N Engl J Med. 2018 Sep 27;379(13):1205-1215. doi: 10.1056/NEJMoa1800781.

14.

An interactive assistant for patients with cardiac implantable electronic devices: A study protocol of the LUCY trial.

Michalik J, Cacko A, Poliński J, Pawlik K, Tataj E, Gawałko M, Opolski G, Grabowski M.

Medicine (Baltimore). 2018 Sep;97(39):e12556. doi: 10.1097/MD.0000000000012556.

15.

Novel biochemical predictors of unfavorable prognosis for stable coronary disease.

Cacko A, Kondracka A, Gawałko M, Główczyńska R, Filipiak KJ, Bartoszewicz Z, Opolski G, Grabowski M.

Medicine (Baltimore). 2018 Sep;97(37):e12372. doi: 10.1097/MD.0000000000012372.

16.

Endovascular extraction of entrapped long-term central feeding catheter: Case series.

Michalak M, Januszkiewicz Ł, Majstrak F, Gawałko M, Opolski G, Grabowski M.

J Vasc Access. 2019 May;20(3):329-332. doi: 10.1177/1129729818792822. Epub 2018 Aug 30.

PMID:
30165799
17.

Implantation of the Micra transcatheter pacing system: Single Polish center experience with the real costs of hospitalization analysis.

Grabowski M, Michalak M, Gawałko M, Gajda S, Cacko A, Januszkiewicz Ł, Kołodzińska A, Mitkowski PP, Duray GZ, Opolski G.

Cardiol J. 2018 Aug 29. doi: 10.5603/CJ.a2018.0075. [Epub ahead of print]

18.

In-hospital heart rate reduction and its relation to outcomes of heart failure patients with sinus rhythm: Results from the Polish part of the European Society of Cardiology Heart Failure Pilot and Long-Term Registries.

Balsam P, Peller M, Borodzicz S, Kapłon-Cieślicka A, Ozierański K, Tymińska A, Marchel M, Crespo-Leiro MG, Maggioni AP, Drożdż J, Grabowski M, Filipiak KJ, Opolski G.

Cardiol J. 2018 Aug 29. doi: 10.5603/CJ.a2018.0094. [Epub ahead of print]

19.

Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center.

Grabowski M, Gawałko M, Michalak M, Cacko A, Kowara M, Kołodzińska A, Januszkiewicz Ł, Balsam P, Vitali Serdoz L, Winter J, Opolski G.

Cardiol J. 2018 Apr 3. doi: 10.5603/CJ.a2018.0024. [Epub ahead of print]

20.

Appropriate and effective interventions of subcutaneous implantable cardioverter-defibrillator (S-ICD): single-academic-centre experience.

Ozierański K, Michalak M, Tymińska A, Balsam P, Grabowski M.

Kardiol Pol. 2018;76(2):474. doi: 10.5603/KP.2018.0045. No abstract available.

Supplemental Content

Loading ...
Support Center